Aims and Scope
Expert Review of Hematology is a MEDLINE-indexed, peer-reviewed, international medical journal publishing review articles and original papers on all aspects of hematology. It is part of the Expert Review series, published by Informa.
Key Metrics
4.2
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
49
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.83
5-Year SI
5-year SI
- N/A 2-year SI
- 0.86 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q2
Hematology
SJR
- Q2 Hematology
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.99
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
23%
4 to 6 months
51%
7 to 9 months
19%
Above 9 months
8%
Did you find this useful?
Thank you for your feedback.
Topics Covered
- Lymphoma
- Flow cytometry
- Anticoagulant
- Hypophosphatemia
- Anemia
- Immune thrombocytopenia
- Proteasome inhibitor
- Minimal residual disease
- Immunotherapy
- Aplastic anemia
- Diffuse large B-cell lymphoma
- Disease
- Hematopoietic stem cell transplantation
- Iron deficiency
- Venetoclax
- Pathophysiology
- Acute bleeding
- Magnetic resonance imaging
- Drug resistance
- Ankle
Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2008 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Expert Review of Hematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Spontaneous regression in mature T-cell non-Hodgkin lymphoma
- 10 Dec 24
- Expert Review of Hematology
-
Full paper
Understanding and overcoming resistance to tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML)
- 10 Dec 24
- Expert Review of Hematology
-
Full paper
Pegcetacoplan: the first and only C3-targeted therapy for the treatment of adults with paroxysmal nocturnal hemoglobinuria.
- 10 Dec 24
- Expert review of hematology
-
Full paper
NSAIDS/COXIBS for the treatment of musculoskeletal pain secondary to hemophilic arthropathy
- 5 Dec 24
- Expert Review of Hematology
-
Full paper
Novel approaches for preventing COVID-19 infection in immunocompromised patients with hematologic malignancies
- 5 Dec 24
- Expert Review of Hematology
-
Full paper
Challenges and emerging therapeutic strategies for TP53-mutated acute myeloid leukemia: still disappointing findings?
- 5 Dec 24
- Expert Review of Hematology
Scite analysis
Powered by scite_
1.6k articles received 19.5k citations see all
- 352 Supporting
- 18,418 Mentioning
- 55 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 6 Corrections
- 6 Errata
- 0 Expression of Concern
FAQs
How long has Expert Review of Hematology been actively publishing?
Expert Review of Hematology has been in operation since 2008 till date.
What is the publishing frequency of Expert Review of Hematology ?
Expert Review of Hematology published with a Bi-monthly frequency.
How many articles did Expert Review of Hematology publish last years ?
In 2023, Expert Review of Hematology published 117 articles.
What is the eISSN & pISSN for Expert Review of Hematology ?
For Expert Review of Hematology,eISSN is 1747-4094 and pISSN is1747-4086.
What is Citescore for Expert Review of Hematology ?
Citescore for Expert Review of Hematology is 4.2.
What is H index for Expert Review of Hematology ?
H index for Expert Review of Hematology is 49.
What is SNIP score for Expert Review of Hematology ?
SNIP score for Expert Review of Hematology is 0.99.
What is the SJR for Expert Review of Hematology ?
SJR for Expert Review of Hematology is Q2.
Who is the publisher of Expert Review of Hematology ?
TAYLOR & FRANCIS LTD is the publisher of Expert Review of Hematology.